112 related articles for article (PubMed ID: 7232826)
21. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
Pavelka K; Müller W
Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501
[No Abstract] [Full Text] [Related]
22. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
[TBL] [Abstract][Full Text] [Related]
23. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
Hsiao YY; Bardos TJ; Wampler GL; Regelson W
J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
[TBL] [Abstract][Full Text] [Related]
24. Effects of BM 12,531 (azimexon) on in vitro lymphocyte and macrophage proliferation.
Hadden JW; Coffey RG
Recent Results Cancer Res; 1980; 75():162-4. PubMed ID: 7232828
[TBL] [Abstract][Full Text] [Related]
25. Effect of carbazilquinone on lymphoid leukemia L-1210.
Arakawa M; Aoki T; Nakao H
Gan; 1970 Oct; 61(5):485-93. PubMed ID: 5476838
[No Abstract] [Full Text] [Related]
26. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
[No Abstract] [Full Text] [Related]
27. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
Arakawa M
Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
[No Abstract] [Full Text] [Related]
28. Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study.
Schiffer CA; Davis RB; Mayer RJ; Peterson BA; Lee EJ
Cancer Treat Rep; 1987 Sep; 71(9):879-80. PubMed ID: 3621225
[No Abstract] [Full Text] [Related]
29. Up-to-date improvements in inorganic ring systems as anticancer agents.
Labarre JF
Top Curr Chem; 1982; 102():1-87. PubMed ID: 6750846
[No Abstract] [Full Text] [Related]
30. [Status of plasma blood clotting factors during different stages of erythromyelosis in rats and the effect of hexaphosphamide on the indices studied].
Stepanian MA; Chilingarian AG; Muradian LB
Zh Eksp Klin Med; 1978; 18(2):24-8. PubMed ID: 278414
[No Abstract] [Full Text] [Related]
31. Influence of ciamexon on blood glucose and insulin requirement in newly manifested type I diabetics. Results of a pilot study.
Hogan M; Beyer J; Stuermer W; Weber P; Schrezenmeier J
Arzneimittelforschung; 1988 Aug; 38(8):1185-9. PubMed ID: 3058137
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
Cates LA; Cramer MB; Williams L
J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
[TBL] [Abstract][Full Text] [Related]
33. [Complex treatment of bladder cancer with pre- and postoperative chemotherapy].
Klimenko IA; Goĭkhberg MI; Zaparin VK; Iaremko VN; Sakalo VS
Urol Nefrol (Mosk); 1987; (1):26-8. PubMed ID: 3564196
[No Abstract] [Full Text] [Related]
34. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
Noell CW; Cheng CC
J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
[No Abstract] [Full Text] [Related]
35. [Chemotherapy of chronic lymphocytic leukemia].
Gerhartz H
Med Klin; 1967 Aug; 62(32):1237-9. PubMed ID: 4969643
[No Abstract] [Full Text] [Related]
36. Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
Ishizuka M; Masuda T; Kanbayashi N; Watanabe Y; Matsuzaki M; Sawazaki Y; Ohkura A; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Aug; 35(8):1049-54. PubMed ID: 7142006
[TBL] [Abstract][Full Text] [Related]
37. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
38. Effects of a new antibiotic, isohematinic acid, on the resistance of mice to experimental infections.
Shiraishi A; Katayama T; Matsuda T; Itoh Y; Haneishi T
Microbiol Immunol; 1987; 31(5):461-8. PubMed ID: 3309579
[TBL] [Abstract][Full Text] [Related]
39. Effect of carbazilquinone on leukemic cell count in various tissues of mice bearing leukemia L-1210.
Arakawa M; Okada N
Gan; 1974 Feb; 65(1):21-5. PubMed ID: 4825388
[No Abstract] [Full Text] [Related]
40. [Results of experimental and clinical studies of a new antileukemic drug: hexaphosphamide. Review of the literature and the author's own results].
Khomchenovskii EI
Haematologia (Budap); 1977; 11(1-2):115-26. PubMed ID: 352850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
